Ann: Imugene completes $90 M placement and launches $5 M SPP, page-251

My view is we will see a dividend this financial year.

LC has already flagged a spectacular announcement with regard to Oncarlytics.

Spectacular=A big upfront + Milestones + Funding.

Oncarlytics= US$480bn PA (AU$650bn) in sales. Solid Tumours are an untapped market. IMU is the first and only company that has solved this puzzle.

PH will not let anybody touch it without a sizeable show of faith

This could very well break all records for a Pre-Clinical early stage deal.

It’s a pity we lost Unbelievable’s input. He wound know what held the record previously.

IMU will easily declare a dividend because BP will be underwriting the trials. As was also indicated with regards with all the other approaches being made for CF33 and outside CarT therapies.

Paul did say this will be a very profitable year for IMU shareholders. Profitable infers a profit and dividend.

Hold tight and add more when you can afford it.

Im still amazed how many people still can’t read this .